CClinicalTrials.gg
RecruitingNCT05277818Updated Oct 31, 2022

Post-marketing Clinical Follow-up of the Medical Device DIVA®

An observational study in Lumbar Disc Herniation, sponsored by SC Medica. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-31.

Sponsored by SC Medica · Observational

From the registry’s dates

  • Started Sep 2022; still recruiting 4 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
822
Ages
18 Years and older
Sex
All
01

Study summary

Observational, ambispective, longitudinal, comparative, open, multicentric study.

The main objective is to compare the performance of care in patients operated with and without DIVA®.

Read the detailed description

The primary endpoint is the reoperation for any cause (excluding trauma) on the lumbar spine.

02

Conditions studied

  • Lumbar Disc Herniation
03

In context

Intervertebral Disc Displacement

478 studies on the registry are indexed under Intervertebral Disc Displacement; 104 are open to participants now.

This study's planned enrollment of 822 is above the median of 100 across 121 observational studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

SC Medica is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients with the DIVA® device operated in the study centers for at least 12 months (with the exception of the first 30 operated by practitioner, to take into account the learning curve), as well as all patients operated on over a period similar before the installation of DIVA® in the establishment, will receive the information note of the study. if the patient agrees to participate to the study, patient's data will be collected on a case report form.

Inclusion criteria

  • Adult patient, having undergone surgery for a degenerative or traumatic mono-segmental lumbar disc herniation, without any other associated pathology, operated with or without a DIVA® implant;
  • Patient operated for at least 12 months;
  • Patient able to understand the information related to the study;
  • Patient having indicated his/her non-opposition to the collection of his/her personal data.

Exclusion criteria

Exclusion Criteria:

  • History of pathologies, malformations or surgical interventions on the spine;
  • Patient belonging to the first 30 operated by the surgeon with the DIVA® implant;
  • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
  • Patient not benefiting from a social security scheme.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
822 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Patient with medical device DIVA®

    Adult patient, operated for at least 12 months, having had surgery for a degenerative or traumatic mono-segmental lumbar disc herniation, without any other associated pathology, operated with DIVA® implant

    Procedure: Surgery lumbar disc herniation

  • Patient without medical device DIVA®

    Adult patient, operated for at least 12 months, having had surgery for a degenerative or traumatic mono-segmental lumbar disc herniation, without any other associated pathology, operated without DIVA® implant

    Procedure: Surgery lumbar disc herniation

Interventions

  • ProcedureSurgery lumbar disc herniation

    Surgery for a degenerative or traumatic mono-segmental lumbar disc herniation

06

What researchers measure

Primary outcomes

  1. Rates of patients requiring reoperation for any cause (excluding trauma) on the lumbar spine 5 years postoperatively.

    The main analysis will compare the rates of patients requiring reoperation due to any cause (excluding trauma) on the lumbar spine 5 years after surgery between the group with DIVA® and the group without DIVA®, using a Chi-square test.

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05277818
Lead sponsor
SC Medica
Responsible party
Sponsor
First posted
Mar 14, 2022
Start date
Sep 7, 2022
Primary completion
Mar 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Oct 31, 2022

Study contacts

Aurélie MULLER
Contact
dpo@sc-medica.com
+33 3 88 23 71 04

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion